Shares of Jazz Pharmaceuticals Inc. (NASDAQ: JAZZ)
are seeing a huge rally in trading today after the Palo Alto, California-based
company provided financial outlook for 2012 reflecting the planned business
combination with Azur Pharma Public Limited Company. The company expects total
revenue for 2012 to come in between $465 million and $490 million.
Jazz Pharmaceuticals shares rose to an intra-day
high of $46.65 in trading today. At last check, the stock was up more than 9%
on above average volume. The rally has pushed Jazz Pharmaceuticals shares above
their 50-day and 200-day moving averages.
To get more information on Jazz Pharmaceuticals Inc.
please click here…
